Immunic, Inc. announced the appointment of Erik Lundgren as chief executive officer, effective May 22, 2026, with employment beginning June 1. The leadership change is a governance update rather than an operating or financial disclosure, so the immediate market impact appears limited.
Immunic, Inc. announced the appointment of Erik Lundgren as chief executive officer, effective May 22, 2026, with employment beginning June 1. The leadership change is a governance update rather than an operating or financial disclosure, so the immediate market impact appears limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
